MedTrace Logo

Registry of Hypogonadism in Men

NCT00858650 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 999

Last updated 2016-08-24

No results posted yet for this study

Summary

The primary objective of the Registry of HYpogonadism in MEn (RHYME) is to establish and maintain a large, multi-national prospective registry of male patients who have been diagnosed with male hypogonadism (HG), also known as androgen deficiency or testosterone deficiency.

Conditions

  • Male Hypogonadism
  • Androgen Deficiency
  • Testosterone Deficiency

Interventions

OTHER

Standard of Care

Standard of care may or may not include use of testosterone replacement therapy

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Besins Healthcare

    collaborator INDUSTRY

  • Carelon Research

    lead OTHER

Principal Investigators

  • Raymond Rosen, PhD · New England Research Institutes, Inc

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Germany
  • Italy
  • Netherlands
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00858650 on ClinicalTrials.gov